Bryn Mawr Capital Management LLC Buys 4,191 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

Bryn Mawr Capital Management LLC increased its stake in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 12.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 38,560 shares of the company’s stock after acquiring an additional 4,191 shares during the quarter. Bryn Mawr Capital Management LLC’s holdings in Church & Dwight were worth $3,782,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of CHD. Creative Planning boosted its holdings in shares of Church & Dwight by 4.9% during the 3rd quarter. Creative Planning now owns 55,434 shares of the company’s stock valued at $5,805,000 after purchasing an additional 2,578 shares during the last quarter. Raymond James & Associates lifted its position in shares of Church & Dwight by 1.8% in the third quarter. Raymond James & Associates now owns 318,499 shares of the company’s stock worth $33,353,000 after buying an additional 5,528 shares in the last quarter. Eastern Bank purchased a new stake in shares of Church & Dwight in the third quarter worth about $907,000. Global X Japan Co. Ltd. grew its holdings in Church & Dwight by 5.7% during the 3rd quarter. Global X Japan Co. Ltd. now owns 4,204 shares of the company’s stock valued at $440,000 after buying an additional 228 shares in the last quarter. Finally, International Assets Investment Management LLC bought a new stake in Church & Dwight in the 3rd quarter worth approximately $44,630,000. 86.60% of the stock is owned by hedge funds and other institutional investors.

Church & Dwight Stock Performance

CHD stock opened at $104.33 on Thursday. The firm has a market cap of $25.66 billion, a price-to-earnings ratio of 44.02, a PEG ratio of 3.30 and a beta of 0.59. Church & Dwight Co., Inc. has a twelve month low of $96.35 and a twelve month high of $113.50. The company has a quick ratio of 1.24, a current ratio of 1.70 and a debt-to-equity ratio of 0.51. The business’s fifty day simple moving average is $105.40 and its two-hundred day simple moving average is $104.66.

Church & Dwight (NYSE:CHD) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.77 EPS for the quarter, hitting the consensus estimate of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same period in the prior year, the firm posted $0.65 EPS. Analysts predict that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current year.

Church & Dwight Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Friday, February 14th will be issued a $0.295 dividend. This is a positive change from Church & Dwight’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.18 dividend on an annualized basis and a dividend yield of 1.13%. Church & Dwight’s payout ratio is presently 49.79%.

Analyst Upgrades and Downgrades

CHD has been the subject of a number of research reports. Stifel Nicolaus increased their target price on Church & Dwight from $103.00 to $105.00 and gave the company a “hold” rating in a research report on Monday, February 3rd. Barclays increased their price objective on shares of Church & Dwight from $90.00 to $93.00 and gave the company an “underweight” rating in a research report on Tuesday, February 4th. Wells Fargo & Company boosted their target price on shares of Church & Dwight from $113.00 to $115.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Truist Financial increased their price target on shares of Church & Dwight from $110.00 to $115.00 and gave the company a “buy” rating in a report on Monday, February 3rd. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Church & Dwight from $114.00 to $115.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Church & Dwight presently has an average rating of “Hold” and an average price target of $111.53.

Insider Buying and Selling

In other news, EVP Rick Spann sold 39,520 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $112.00, for a total value of $4,426,240.00. Following the completion of the sale, the executive vice president now owns 4,973 shares of the company’s stock, valued at approximately $556,976. This represents a 88.82 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Joseph James Longo sold 7,780 shares of Church & Dwight stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $112.44, for a total transaction of $874,783.20. Following the transaction, the chief accounting officer now directly owns 400 shares in the company, valued at approximately $44,976. The trade was a 95.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 57,302 shares of company stock valued at $6,362,338 over the last quarter. 2.00% of the stock is owned by corporate insiders.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.